NCT06024447

Brief Summary

Patients of Stage III and Stage IV Periodontitis will be assessed for masticatory dysfunction and psychological distress. Subgingival Instrumentation will be done for treating periodontitis. Patients will be re-evaluated after 2 and 3 months in order to assess any change in masticatory dysfunction and psychological distress by improved periodontal health.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 6, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

September 15, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2024

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

August 10, 2023

Last Update Submit

May 16, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Masticatory performance

    Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum, through optoelectronic analysis using a software. Subjective masticatory performance will be calculated using The Quality of Masticatory Function questionnaire which consists of 29 questions related to frequency and difficulty of chewing different types of foods in the previous 2 weeks.

    Baseline, 2 months, 3 months

  • Hospital Anxiety and Depression Scale 14

    The HADS constitutes 14 items grouped into two subscales: "anxiety subscale" (HADS-A), as well as "depression subscale" (HADS-D). The responses to the items are graded from 0 (absence of manifestations) to 3 (severe manifestations). Scores are summated to yield the total score, and greater scores indicate more severe anxiety, as well as depressive indications. DASS-21 measures emotional distress in three subcategories of depression (e.g., loss of self-esteem/incentives and depressed mood), anxiety (e.g., fear and anticipation of negative events), and stress (e.g., persistent state of over arousal and low frustration tolerance). It is a self-reporting questionnaire with 21 items (seven items for each category) based on a four-point rating scale. Higher score represents more severe emotional distress.

    Baseline, 2 months, 3 months

  • Depression Anxiety and Stress Scale 21

    DASS-21 measures emotional distress in three subcategories of depression (e.g., loss of self-esteem/incentives and depressed mood), anxiety (e.g., fear and anticipation of negative events), and stress (e.g., persistent state of over arousal and low frustration tolerance). It is a self-reporting questionnaire with 21 items (seven items for each category) based on a four-point rating scale. Higher score represents more severe emotional distress.

    Baseline, 2 months, 3 months

Secondary Outcomes (2)

  • Pocket Probing Depth

    Baseline, 2 months, 3 months

  • Clinical attachment level

    Baseline, 2 months, 3 months

Study Arms (1)

Stage III and Stage IV Periodontitis

OTHER

Subgingival Instrumentation will be performed in patients with Stage III and Stage IV periodontitis.

Procedure: Subgingival Instrumentation

Interventions

Subgingival Instrumentation will be performed in patients with Stage III and IV periodontitis.

Stage III and Stage IV Periodontitis

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients with age group 30-50 years diagnosed with stage III/IV generalized periodontitis.
  • Presence of minimum 20 teeth (Eichner group A1, A2, A3) excluding third molars.

You may not qualify if:

  • Systemic diseases that may affect periodontal disease progression or outcome of treatment (diabetes, autoimmune diseases)
  • Systemic diseases that may affect masticatory ability of the patient (sarcopenia, TMJ disorders, Xerostomia, Acute Pulpitis)
  • Periodontal treatment within the 6 months
  • Patients wearing orthodontic appliances
  • Any diagnosed psychiatric disorder
  • Antibiotic use within the previous 3 months
  • Steroid, immunosuppressive and psychiatric drug use
  • Pregnant and lactating women
  • History of menopause
  • Smoking or substance abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Post Graduate Institute of Dental Sciences

Rohtak, Haryana, 124001, India

RECRUITING

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Janvi Janvi, BDS

    PGIDS Rohtak

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sanjay Tewari, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2023

First Posted

September 6, 2023

Study Start

September 15, 2023

Primary Completion

September 15, 2024

Study Completion

October 15, 2024

Last Updated

May 17, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations